Log in to save to my catalogue

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullo...

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f5b3a549b71047a8af916b003c2c5071

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

About this item

Full title

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

Publisher

England: BioMed Central Ltd

Journal title

Orphanet journal of rare diseases, 2019-12, Vol.14 (1), p.278-278, Article 278

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Dystrophic epidermolysis bullosa (DEB) is a hereditary skin fragility disorder, characterized by trauma-induced blistering followed by soft tissue fibrosis. One of the most feared complications is the early development of aggressive cutaneous squamous cell carcinomas (SCC). For patients with locally advanced or metastasized SCCs treatment with cetu...

Alternative Titles

Full title

EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f5b3a549b71047a8af916b003c2c5071

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f5b3a549b71047a8af916b003c2c5071

Other Identifiers

ISSN

1750-1172

E-ISSN

1750-1172

DOI

10.1186/s13023-019-1262-7

How to access this item